| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AC05) | ustekinumab; parenteral | 884 | |
| PURCH | PURCH_ATC(L04AC10) | secukinumab; parenteral | 797 | |
| PURCH | PURCH_ATC(L04AC13) | ixekizumab; parenteral | 547 | |
| PURCH | PURCH_ATC(L04AC07) | tocilizumab; parenteral | 508 | |
| PURCH | PURCH_ATC(L04AC18) | risankizumab; parenteral | 404 | |
| PURCH | PURCH_ATC(L04AC16) | guselkumab; systemic | 348 | |
| PURCH | PURCH_ATC(L04AC14) | sarilumab; systemic | 252 | |
| PURCH | PURCH_ATC(L04AC21) | bimekizumab; systemic | 179 | |
| PURCH | PURCH_ATC(L04AC03) | anakinra; parenteral | 47 | |
| PURCH | PURCH_ATC(L04AC12) | brodalumab; systemic | 11 | |
| PURCH | PURCH_ATC(L04AC17) | tildrakizumab; parenteral | 5 |